BlackBerry Ltd (NASDAQ:BBRY) options are flying off the shelves, as traders place bets ahead of the company’s turn in the earnings confessional tomorrow morning. Roughly 61,000 calls and 24,000 puts have traded thus far, compared to the stock’s average intraday volume of around 36,000 calls and 15,000 puts. What’s more, BBRY’s 30-day at-the-money implied volatility (IV) is 8.2% higher at 72.4%, reflecting the escalating pre-earnings demand for short-term contracts. BlackBerry Ltd (NASDAQ:BBRY) shares after opening at $9.20 moved to $9.64 on last trade day and at the end of the day closed at $8.41. Company price to sales ratio in past twelve months was calculated as 0.35 and price to cash ratio as 1.61. BlackBerry Ltd (NASDAQ:BBRY) showed a negative weekly performance of -8.39%.
MannKind Corporation (NASDAQ:MNKD)’s shares climbed 5.21% to $5.47. The company on Feb. 18 reported financial results for the fourth quarter and full year ended December 31, 2013. The net loss applicable to common stockholders for fiscal year 2013 was $(191.5) million, or $(0.64) per share based on 299.6 million weighted average shares outstanding, compared with a net loss applicable to common stockholders of $(169.4) million, or $(0.94) per share based on 180.9 million weighted average shares outstanding for fiscal year 2012. MannKind Corporation (NASDAQ:MNKD) shares fell -7.12% in last trading session and ended the day on $4.83. MannKind Corporation (NASDAQ:MNKD) return on equity ratio is recorded as 153.90% and its return on assets is -78.70%. MannKind Corporation (NASDAQ:MNKD) yearly performance is 42.48%.
FuelCell Energy Inc (NASDAQ:FCEL) has by far been a better-known hydrogen-fuel producer in comparison to a number of other peers in the solar industry. This company is also known to be a manufacturer of fuel cell power as well. FuelCell Energy Inc (NASDAQ:FCEL) shares moved down -5.37% in last trading session and was closed at $2.29, while trading in range of $ 2.29 – 2.45. FuelCell Energy Inc (NASDAQ:FCEL) year to date (YTD) performance is 62.41%.
Inovio Pharmaceuticals Inc(NYSEMKT:INO)’s shares dropped 6.32% to $3.41. The company on Mar. 26 announced that it was recognized with three industry awards at the World Vaccine Congress, which is being held this week in Washington, D.C. The Vaccine Industry Excellence (ViE) Awards recognize outstanding vaccine advancements and achievements of therapeutic and preventive vaccine developers across the global industry as judged by a panel of global biotech industry stakeholders. Inovio Pharmaceuticals Inc (NYSEMKT:INO) weekly performance is -11.11%. On last trading day company shares ended up $3.28. Inovio Pharmaceuticals Inc (NYSEMKT:INO) distance from 50-day simple moving average (SMA50) is 7.28%. Analysts mean target price for the company is $4.60.
Leave a Reply